Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Recruiting · NCT06321536 · Registry updated 2025-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT) | Multi-Drug Resistant Organism Colonization | Recruiting | Phase 2 | 2025-11-05 | NCT06321536 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centers for Disease Control and Prevention | 84 |
| Emory University | 393 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| A.G Rhodes Wesley Woods | Atlanta | United States | 1 |
| Emory Long Term Acute Care (LTAC) | Decatur | United States | 1 |
| Penn Medicine Rittenhouse | Philadelphia | United States | 2 |
| RML Specialty Hospital | Hinsdale | United States | 2 |